94.98
Zimmer Biomet Holdings Inc stock is traded at $94.98, with a volume of 1.94M.
It is up +0.64% in the last 24 hours and down -1.86% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$94.38
Open:
$95
24h Volume:
1.94M
Relative Volume:
0.97
Market Cap:
$18.12B
Revenue:
$8.41B
Net Income/Loss:
$760.80M
P/E Ratio:
24.66
EPS:
3.8513
Net Cash Flow:
$1.05B
1W Performance:
+6.55%
1M Performance:
-1.86%
6M Performance:
+0.21%
1Y Performance:
-4.94%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings Inc
|
94.98 | 18.12B | 8.41B | 760.80M | 1.05B | 3.8513 |
|
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-26 | Initiated | Barclays | Equal Weight |
| Jul-28-26 | Initiated | UBS | Buy |
| Jul-09-26 | Initiated | BMO Capital Markets | Market Perform |
| Mar-23-26 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-20-26 | Initiated | William Blair | Mkt Perform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Sept. 3: Zimmer Biomet moving HQ, donating former one to area college - KPCNews
Zimmer Biomet extends exclusive deal to distrib... - Pluang
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT - PR Newswire
Zimmer Biomet Holdings Inc. R (ZIM.MU) Q2 FY2026 earnings call transcript - Yahoo Finance
Surgical Equipment & ConsumablesDiversified Stocks Q2 Results: Benchmarking Zimmer Biomet (NYSE:ZBH) - Yahoo Finance
Is It Too Late to Buy Zimmer Biomet Holdings Inc (ZBH) After 3.4% Rally? GF Value Says Undervalued - GuruFocus
Zimmer Biomet gains as investors weigh analyst optimism and prior guidance lift - Quiver Quantitative
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Form 4 Zimmer Biomet Holdings Inc For: 12 October By Investing.com - Investing.com Nigeria
Should Value Investors Buy Zimmer Biomet (ZBH) Stock? - Zacks Investment Research
Should Value Investors Buy Zimmer Biomet (ZBH) Stock? - Yahoo Finance
Leerink Partners Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $97 - Moomoo
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy? - Zacks Investment Research
Zimmer Biomet Holdings Inc Share PriceZBH, RNS News, Articles, Quotes, & Charts (NYSE:ZBH) - Proactive financial news
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - Investing News Network
Are Investors Undervaluing Baxter International (BAX) Right Now? - Zacks Investment Research
On Nov. 4, Q3 results release will be available at 6:30 a.m. ET before Zimmer Biomet's webcast. - Stock Titan
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - themountaineer.com
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - Yahoo Finance
A Look at Zimmer Biomet Holdings Inc (ZBH) After 3.7% Gain -- GF Value $125.41 vs Price $91.57 - GuruFocus
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
932 and 480 shares are withheld for taxes as Zimmer Biomet (ZBH) stock awards convert. - Stock Titan
Options on 7,035 shares expire in 2032 for Zimmer Biomet (ZBH) executive Brian Hatcher. - Stock Titan
Fully vested options are among Americas president Gary Craig Campbell's Zimmer Biomet (ZBH) holdings. - Stock Titan
Citi Initiates 90-Day Watch on Zimmer Biomet (ZBH) Ahead of Q3 E - GuruFocus
Zimmer Biomet Holdings Inc. (ZIM.SG) Q2 FY2026 earnings call transcript - Yahoo Finance
ZBH6004607 Bond Profile: Coupon and Redemption - TradingView
A director at Zimmer Biomet (ZBH) acquired 417.363 units payable in cash. - Stock Titan
A director acquires 306 cash-settled stock units at Zimmer Biomet (ZBH), payable in five annual installments. - Stock Titan
Director Arthur J. Higgins acquires 306.066 cash-settled units at Zimmer Biomet (ZBH). - Stock Titan
Director acquires 375.626 cash-settled stock units at Zimmer Biomet (ZBH). - Stock Titan
A director acquires 174 deferred stock units at Zimmer Biomet (ZBH), payable in shares after service ends. - Stock Titan
Director Kolli acquires 173.901 deferred stock units at Zimmer Biomet (ZBH). - Stock Titan
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com
Zimmer Biomet stock after-hours at EUR 78.77 - AD HOC NEWS
Why Are Traders Reassessing Zimmer Biomet (NYSE:ZBH)? - Kalkine Media
CH147843074 Bond Profile: Coupon and Redemption - TradingView
Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by Envestnet Asset Management Inc. - MarketBeat
Zimmer Biomet stock holds at USD 91.62 as BMO keeps target - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shareholders to Get $0.24 Quarterly Dividend - MarketBeat
Zimmer Biomet (ZBH) Stock Forecast and Price Target 2026 $ZBH - MarketBeat
ZBH5302814 Bond Profile: Coupon and Redemption - TradingView
ZBH6004608 Bond Profile: Coupon and Redemption - TradingView
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings (ZBH) Pushes Cost Reset Plans, Is It Still 17% Below Fair Value? - Yahoo Finance
Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by State Street Corp - MarketBeat
A Look at Zimmer Biomet Holdings Inc (ZBH) After 3.3% Decline -- GF Value $125.18 vs Price $90.88 - GuruFocus
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zimmer Biomet Holdings Inc Stock (ZBH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thornal Kevin R | Grp Pres-Global Business |
Sep 11 '26 |
Sale |
92.95 |
5,691 |
528,978 |
0 |
| Thornal Kevin R | Officer |
Sep 11 '26 |
Proposed Sale |
92.95 |
5,691 |
528,978 |
0 |
| Phipps Chad F | Officer |
Sep 04 '26 |
Proposed Sale |
98.35 |
3,000 |
295,050 |
0 |
| Phipps Chad F | See remarks below. |
Sep 04 '26 |
Sale |
98.35 |
3,000 |
295,050 |
65,231 |
| Thornal Kevin R | Grp Pres-Global Business |
Aug 01 '26 |
Option Exercise |
0.00 |
9,957 |
0 |
9,957 |
| Upadhyay Suketu | Former Officer |
Jul 16 '26 |
Proposed Sale |
92.86 |
7,668 |
712,050 |
0 |
| Upadhyay Suketu | Former Officer |
Jun 24 '26 |
Proposed Sale |
90.07 |
4,560 |
410,696 |
0 |
| Yi Sang | Group President, Asia Pacific |
May 29 '26 |
Sale |
82.64 |
5,000 |
413,216 |
27,251 |
| Yi Sang | Officer |
May 29 '26 |
Proposed Sale |
82.64 |
5,000 |
413,216 |
0 |
| Upadhyay Suketu | Former Officer |
May 19 '26 |
Proposed Sale |
86.38 |
5,373 |
464,120 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):